Skip to main content

Berkley and Jensen Acid Reducer Maximum Strength Disease Interactions

There are 6 disease interactions with Berkley and Jensen Acid Reducer Maximum Strength (ranitidine).

Major

H2 antagonists (applies to Berkley and Jensen Acid Reducer Maximum Strength) GI bleeding

Major Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Hemorrhage

Histamine H2 receptor antagonists should not be used in the presence of vomit with blood, or bloody or black stools. These might be serious conditions and the diagnosis needs to be ruled out.

Switch to professional interaction data

Major

Ranitidine (applies to Berkley and Jensen Acid Reducer Maximum Strength) porphyria

Major Potential Hazard, Moderate plausibility.

Ranitidine may rarely precipitate acute porphyria attacks and should be avoided in patients with a history of acute porphyria.

Switch to professional interaction data

Moderate

Ranitidine (applies to Berkley and Jensen Acid Reducer Maximum Strength) hemodialysis

Moderate Potential Hazard, High plausibility.

Ranitidine is partially removed by hemodialysis and should be administered after dialysis.

Switch to professional interaction data

Moderate

Ranitidine (applies to Berkley and Jensen Acid Reducer Maximum Strength) liver disease

Moderate Potential Hazard, Low plausibility.

Ranitidine is partially metabolized by the liver. Although dosage reductions are generally not necessary, therapy with ranitidine should be administered cautiously in patients with liver disease. Elevated ALT (SGPT) has been observed in patients receiving ranitidine intravenously at dosages greater than those normally recommended for 5 days or more.

Switch to professional interaction data

Moderate

Ranitidine (applies to Berkley and Jensen Acid Reducer Maximum Strength) PKU

Moderate Potential Hazard, High plausibility. Applicable conditions: Phenylketonuria

Zantac (brand of ranitidine) 150 EFFERdose tablets and granules both contain 16.84 mg of phenylalanine per each 150 mg of ranitidine. The phenylalanine content should be considered when these products are used in patients who must restrict their intake of phenylalanine (i.e. phenylketonurics).

Switch to professional interaction data

Moderate

Ranitidine (applies to Berkley and Jensen Acid Reducer Maximum Strength) renal dysfunction

Moderate Potential Hazard, High plausibility.

Ranitidine is primarily eliminated by the kidney. Although the drug is generally well-tolerated, the daily dosage should initially be reduced in patients with moderate to severe renal impairment (CrCl < 50 mL/min). If necessary, the daily dosage may be increased with caution.

Switch to professional interaction data

Berkley and Jensen Acid Reducer Maximum Strength drug interactions

There are 141 drug interactions with Berkley and Jensen Acid Reducer Maximum Strength (ranitidine).

Berkley and Jensen Acid Reducer Maximum Strength alcohol/food interactions

There is 1 alcohol/food interaction with Berkley and Jensen Acid Reducer Maximum Strength (ranitidine).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer